tiprankstipranks
Trending News
More News >
THC Farmaceuticals Inc (CBDG)
OTHER OTC:CBDG
US Market
Advertisement

THC Farmaceuticals (CBDG) Ratios

Compare
22 Followers

THC Farmaceuticals Ratios

CBDG's free cash flow for Q3 2022 was $0.00. For the 2022 fiscal year, CBDG's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
0.12 4.67 1.15 1.19 0.60
Quick Ratio
0.12 4.67 1.15 1.19 0.60
Cash Ratio
0.01 0.01 0.03 <0.01 <0.01
Solvency Ratio
-0.07 3.03 -0.01 -0.11 -0.46
Operating Cash Flow Ratio
4.47 2.24 -0.02 >-0.01 -0.12
Short-Term Operating Cash Flow Coverage
4.49 2.25 -0.03 >-0.01 -0.15
Net Current Asset Value
$ -125.68K$ 520.83K$ 90.97K$ 106.82K$ -436.43K
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.13 0.15 0.36
Debt-to-Equity Ratio
0.04 0.04 0.13 0.15 0.47
Debt-to-Capital Ratio
0.04 0.04 0.12 0.13 0.32
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
0.86 0.86 1.00 0.99 1.29
Debt Service Coverage Ratio
-0.18 -0.03 -0.02 -0.17 -0.54
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.34 0.04 0.41 0.21 0.18
Interest Debt Per Share
<0.01 <0.01 0.02 0.02 0.06
Net Debt to EBITDA
-5.59 0.33 -22.32 -2.84 -0.92
Profitability Margins
Gross Profit Margin
0.00%61.92%57.39%100.00%74.16%
EBIT Margin
0.00%4260.61%-752.28%-1592.73%-9762.99%
EBITDA Margin
0.00%4298.69%-709.67%-1580.16%-9753.64%
Operating Profit Margin
0.00%-84.91%-797.22%-431.68%-1550.97%
Pretax Profit Margin
0.00%4260.61%-752.28%-1592.73%-9762.99%
Net Profit Margin
0.00%4269.05%-376.90%-797.95%-4891.26%
Continuous Operations Profit Margin
0.00%4260.61%-752.28%-1592.73%-9762.99%
Net Income Per EBT
50.00%100.20%50.10%50.10%50.10%
EBT Per EBIT
100.00%-5017.80%94.36%368.96%629.48%
Return on Assets (ROA)
-0.55%15.38%-0.30%-2.60%-19.69%
Return on Equity (ROE)
-0.47%13.28%-0.30%-2.58%-25.47%
Return on Capital Employed (ROCE)
-1.15%-0.32%-0.81%-1.84%-10.94%
Return on Invested Capital (ROIC)
-1.09%<0.01%-0.35%-0.77%-3.35%
Return on Tangible Assets
-1.35%37.59%-0.47%-19.92%-168.04%
Earnings Yield
-3.59%11.83%-0.93%-3.71%-9.67%
Efficiency Ratios
Receivables Turnover
0.00 0.02 <0.01 0.01 0.02
Payables Turnover
0.00 0.00 0.03 0.00 0.24
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.44 0.35 1.02 1.22
Asset Turnover
0.00 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
0.00 0.03 0.02 -0.05 0.09
Cash Conversion Cycle
0.00 23.22K 92.20K 30.39K 20.81K
Days of Sales Outstanding
0.00 23.22K 103.71K 30.39K 22.31K
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 11.51K 0.00 1.50K
Operating Cycle
0.00 23.22K 103.71K 30.39K 22.31K
Cash Flow Ratios
Operating Cash Flow Per Share
0.04 0.02 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
0.04 0.02 >-0.01 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
211.85K 63.58K -11.76K 0.00 0.00
Capital Expenditure Coverage Ratio
211.85K 63.58K -11.76K 0.00 0.00
Operating Cash Flow Coverage Ratio
4.49 2.25 -0.03 >-0.01 -0.15
Operating Cash Flow to Sales Ratio
0.00 31.79 -5.26 -0.29 -13.17
Free Cash Flow Yield
152.40%8.81%-1.29%-0.14%-2.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-27.85 8.45 -107.89 -26.94 -10.34
Price-to-Sales (P/S) Ratio
0.00 360.82 406.62 214.95 505.82
Price-to-Book (P/B) Ratio
0.13 1.12 0.33 0.69 2.63
Price-to-Free Cash Flow (P/FCF) Ratio
0.66 11.35 -77.24 -738.09 -38.41
Price-to-Operating Cash Flow Ratio
0.66 11.35 -77.24 -738.09 -38.41
Price-to-Earnings Growth (PEG) Ratio
-0.28 >-0.01 1.25 0.31 >-0.01
Price-to-Fair Value
0.13 1.12 0.33 0.69 2.63
Enterprise Value Multiple
-22.27 8.72 -79.61 -16.44 -6.11
Enterprise Value
556.83K 3.75M 1.26M 1.97M 6.07M
EV to EBITDA
-22.27 8.72 -79.61 -16.44 -6.11
EV to Sales
0.00 374.80 565.00 259.85 595.50
EV to Free Cash Flow
0.88 11.79 -107.33 -892.28 -45.22
EV to Operating Cash Flow
0.88 11.79 -107.32 -892.28 -45.22
Tangible Book Value Per Share
0.05 0.05 0.07 -0.01 -0.05
Shareholders’ Equity Per Share
0.18 0.18 0.15 0.14 0.12
Tax and Other Ratios
Effective Tax Rate
0.00 1.02 0.50 0.50 0.50
Revenue Per Share
0.00 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 0.02 >-0.01 >-0.01 -0.03
Tax Burden
0.50 1.00 0.50 0.50 0.50
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-42.44 0.74 1.40 0.04 0.27
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis